TB-500 is a synthetic version of a naturally occurring peptide fragment derived from thymosin beta-4, a protein involved in tissue repair and regeneration. It is widely researched for its potential to accelerate healing of muscles, tendons, ligaments, connective tissue, and wounds. TB-500 is known for its systemic effects, allowing it to circulate throughout the body and support recovery in multiple tissues simultaneously.
Common Research Dosing Protocol:
Loading Phase (4-6 weeks):
2-2.5 mg twice weekly
Total: 4-5 mg per week
Maintenance Phase:
2-5 mg every 2-4 weeks
Or 2 mg once weekly during periods of heavy training or injury recovery
Administration:
Subcutaneous injection
Intramuscular injection is also commonly used in research settings
Does not generally need to be injected near the injury site due to systemic distribution
Storage:
Refrigerate at 36-46°F (2-8°C) after reconstitution
Protect from light
Do not freeze
Use sterile technique for all withdrawals
Notes:
TB-500 is frequently combined with BPC-157 for injury recovery. A common stack is:
BPC-157: 500 mcg twice daily
TB-500: 2.5 mg twice weekly
Researchers often view BPC-157 as the "local repair" peptide and TB-500 as the "systemic recovery" peptide. Benefits are most commonly reported for tendon injuries, muscle strains, joint discomfort, flexibility, and recovery from intense training. Typical cycles last 8-12 weeks depending on the severity of the injury being addressed.
TB-500 is a synthetic version of a naturally occurring peptide fragment derived from thymosin beta-4, a protein involved in tissue repair and regeneration. It is widely researched for its potential to accelerate healing of muscles, tendons, ligaments, connective tissue, and wounds. TB-500 is known for its systemic effects, allowing it to circulate throughout the body and support recovery in multiple tissues simultaneously.
Common Research Dosing Protocol:
Loading Phase (4-6 weeks):
2-2.5 mg twice weekly
Total: 4-5 mg per week
Maintenance Phase:
2-5 mg every 2-4 weeks
Or 2 mg once weekly during periods of heavy training or injury recovery
Administration:
Subcutaneous injection
Intramuscular injection is also commonly used in research settings
Does not generally need to be injected near the injury site due to systemic distribution
Storage:
Refrigerate at 36-46°F (2-8°C) after reconstitution
Protect from light
Do not freeze
Use sterile technique for all withdrawals
Notes:
TB-500 is frequently combined with BPC-157 for injury recovery. A common stack is:
BPC-157: 500 mcg twice daily
TB-500: 2.5 mg twice weekly
Researchers often view BPC-157 as the "local repair" peptide and TB-500 as the "systemic recovery" peptide. Benefits are most commonly reported for tendon injuries, muscle strains, joint discomfort, flexibility, and recovery from intense training. Typical cycles last 8-12 weeks depending on the severity of the injury being addressed.